To hear about similar clinical trials, please enter your email below
Trial Title:
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
NCT ID:
NCT00582647
Condition:
Esophageal Cancer
Bile Duct Neoplasms
Gastric Cancer
Liver Cancer
Melanoma
Pancreatic Cancer
Sarcoma
Conditions: Official terms:
Sarcoma
Bile Duct Neoplasms
Soft Tissue Neoplasms
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Prospective
Summary:
Doctors at Memorial Sloan Kettering Cancer Center and at other institutions study normal
and cancer cells. To study these cells we need to have human tissue, body fluids, and
blood. The patient will be having or have had a procedure to remove tissue. The doctors
would like to use some of this tissue. The doctors will use it for laboratory studies on
the causes, prevention, diagnosis and treatment of sarcoma, gastrointestinal or other
intra-abdominal cancers. They will only use extra tissue left over after all needed
testing has been done. They would also like to study components of the immune blood cells
and blood serum (the liquid portion of the blood). In some patients they will take a
blood sample before the tissue or body fluid is removed, usually at the same time that
other routine pre-procedure blood tests are drawn. If thet need more blood, it will be
drawn when the patient is seeing the doctor anyway. We will not draw more than 50cc (4-5
tablespoons) at any one time. With the patient's permission, thet may also send a small
portion of the blood and/or a sample of the tissue to a repository at the National Cancer
Institute. This will be used to identify special proteins in the blood or tissue that may
be useful for diagnosing cancer. Information about the treatment and the response to
treatment may be linked to the tissue specimens obtained. This information may be
important for the research studies that will be done on the tissue, body fluid and blood
specimens. All of this information will be kept in strictest confidence; they will use it
only for biomedical research. The patient's name will not be used in any report.
Criteria for eligibility:
Study pop:
Primary Care Clinic
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
For patients:
- All patients with benign or malignant tumors of the soft tissues, gastrointestinal
tract, and other intra-abdominal sites who will have or have had tissue, peritoneal,
pleural, cyst, urine, and/or other gastrointestinal fluid removed for therapeutic or
diagnostic purposes.
- Patients will be entered without preference for any particular racial/ethnic group.
- Patients may have received prior hormonal therapy, cytotoxic chemotherapy,
irradiation, immunotherapy or surgical therapy.
- Tissue and body fluid specimens must be a large enough quantity to allow routine
pathological analysis, with the research laboratory specimen removed from the
residual specimen which would otherwise be discarded.
Healthy Control Subjects:
- Any male or female with no concurrent malignancies (except for localized basal cell
or squamous cell skin cancer) within 5 years of enrollment.
- > or = to 18 years of age
- Any MSKCC employee will be allowed to participate as a healthy control, provided
they fulfill the above inclusion criteria and they enroll willfully and voluntarily
Exclusion Criteria:
Healthy Control Subjects:
- Attending physicians authorized to obtain informed consent may exercise discretion
in excluding individuals for appropriate medical or other (e.g. mentally impaired)
reasons.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Memorial Sloan Kettering Cancer Center
Address:
City:
New York
Zip:
10065
Country:
United States
Start date:
March 2000
Completion date:
December 2024
Lead sponsor:
Agency:
Memorial Sloan Kettering Cancer Center
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Memorial Sloan Kettering Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00582647
http://www.mskcc.org